Generex Announces Distribution Agreement for Generex Oral-lyn in Chile
Generex Biotechnology Corporation announced that it has entered into an exclusive Product Licensing & Distribution Agreement with PMG S.A. (www.pmgpharma.com) for the registration, marketing, distribution and sale of Generex Oral-lyn™, the Company’s proprietary buccal insulin spray product, in Chile.
“We are delighted to have licensed Generex Oral-lyn™ to PMG PHARMA, a well-established company whose principals have a long history in marketing diabetes products,” said Anna Gluskin, Generex’s President & Chief Executive Officer. “This alliance is important as it opens up another key country in South America where diabetes is a highly prevalent condition.”
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.